Standard error of empirical bayes estimate in NONMEM® VI

Korean Journal of Physiology and Pharmacology

Volumn 16, Issue 2, 2012, Pages 97-106

  Kang, Dongwoo ^a   Bae, Kyun Seop ^b   Houk, Brett E ^a   Savic, Radojka M ^c   Karlsson, Mats O ^c  

^a PFIZER INC   (United States)

^b University of Ulsan   (South Korea)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Nonlinear mixed effects modeling; NONMEM; Standard error of empirical bayes estimate

Indexed keywords

PHENOBARBITAL; THEOPHYLLINE;

ARTICLE; BAYES THEOREM; COMPUTER PROGRAM; MATHEMATICAL MODEL; MEASUREMENT ERROR; PHARMACODYNAMICS; PHARMACOKINETICS;

EID: 84861070695     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2012.16.2.97     Document Type: Article

References (13)

1. Lacroix BD, Friberg LE, Karlsson MO. Evaluation of IPPSE, an alternative method for sequential population PKPD analysis. J Pharmacokinet Pharmacodyn. 2012;39:177-193.
2. psn.sourceforge.net [Internet]. PsN: perl-speaks-NONMEM; ©2008 by Mats Karlsson, Niclas Jonsson and Andrew Hooker. [cited 2012 Feb 15]. Available from: http://psn.sourceforge.net.
3. Beal SL, Sheiner LB, Boeckmann AJ (Eds.). NONMEM Users Guides - Part VII. Ellicott City, Maryland, USA.: Icon Development Solutions; 1989-2006.
4. Wang Y. Derivation of various NONMEM estimation methods. J Pharmacokinet Pharmacodyn. 2007;34:575-593. (Pubitemid 47477034)
5. Pawitan Y. In all likelihood: statistical modelling and inference using likelihood. New York: Oxford University Press.; 2001.
6. D'Argenio DZ, Schumitzky A, Wang X. ADAPT 5 User' s Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software. Los Angeles: Biomedical Simulations Resource; 2009.
7. Savic RM, Karlsson MO. Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions. AAPS J. 2009;11:558-569.
8. Balram C, Lim BL, Lee EJ, Wong SY, Ang B. Validity of Bayesian forecasting programme in therapeutic drug monitoring of vancomycin in a surgical intensive care unit: a prospective evaluation. Ann Acad Med Singapore. 1996;25:492-495. (Pubitemid 26334453)
9. el Desoky E, Meinshausen J, Bühl K, Engel G, Harings-Kaim A, Drewelow B, Klotz U. Generation of pharmacokinetic data during routine therapeutic drug monitoring: Bayesian approach vs. pharmacokinetic studies. Ther Drug Monit. 1993;15:281-288. (Pubitemid 23237578)
10. Pons G, Tréluyer JM, Dimet J, Merlé Y. Potential benefit of Bayesian forecasting for therapeutic drug monitoring in neonates. Ther Drug Monit. 2002;24:9-14. (Pubitemid 34106724)
11. Karlsson MO, Savic RM. Diagnosing model diagnostics. Clin Pharmacol Ther. 2007;82:17-20. (Pubitemid 46944205)
12. Park K, Verotta D, Gupta SK, Sheiner LB. Use of a pharmacokinetic/ pharmacodynamic model to design an optimal dose input profile. J Pharmacokinet Biopharm. 1998;26:471-492. (Pubitemid 29153523)
13. Ette EI, Williams PJ. Pharmacometrics - The Science of Quantitative Pharmacology. Hoboken, New Jersey: John Wiley & Sons, Inc.; 2007.